Cold Sores News

The stock last traded at $3.05, down from its previous close of $3.31. Separately, analysts at McNicoll Lewis & Vlak initiated coverage on shares of Avanir Pharmaceuticals in a research note to investors on Friday, January 20th.

It was a peaceful, steady life. After finding a niche teaching foreign medical students how to obtain their visas at Cedars-Sinai, Robin Barr was in her 40s when she was unexpectedly laid off.

The stock last traded at $2.32, up from its previous close of $2.30. Separately, analysts at Canaccord Genuity reiterated a "buy" rating on shares of Avanir Pharmaceuticals Inc in a research note to investors on Wednesday, November 30th.

Cold sores, fever blisters, and oral herpes have plagued millions of people worldwide, always appearing unexpectedly and at the most inopportune times.

The stock last traded at $2.31, down from its previous close of $2.51. Separately, analysts at JMP Securities initiated coverage on shares of Avanir Pharmaceuticals Inc in a research note to investors on Tuesday, August 23rd.